Abstract:
This disclosure relates to amphiphilic compounds containing a cyclobutene or cyclobutane moiety. In some embodiments, the compounds are useful for treating infection by Mycobacterium such as Mycobacterium tuberculosis. Cyclobutene containing compounds are also useful as monomers in the preparation of amphiphilic polymers.
Abstract:
A fluorinated polyvalent carbonyl compound is produced by an economically advantageous method from inexpensive materials without requiring a complicated synthetic process step. Namely, the present invention comprises reacting a polyvalent alcohol having at least two kinds of alcohol skeletons selected among a primary alcohol, a secondary alcohol and a tertiary alcohol, with an acid halide to obtain a polyvalent ester compound, fluorinating it in a liquid phase to obtain a perfluorinated polyvalent ester compound, and cleaving the ester bonds derived from primary and secondary alcohols in the perfluoropolyvalent ester compound to obtain a fluorinated polyvalent carbonyl compound.
Abstract:
A fluorinated polyvalent carbonyl compound is produced by an economically advantageous method from inexpensive materials without requiring a complicated synthetic process step. Namely, the present invention comprises reacting a polyvalent alcohol having at least two kinds of alcohol skeletons selected among a primary alcohol, a secondary alcohol and a tertiary alcohol, with an acid halide to obtain a polyvalent ester compound, fluorinating it in a liquid phase to obtain a perfluorinated polyvalent ester compound, and cleaving the ester bonds derived from primary and secondary alcohols in the perfluoropolyvalent ester compound to obtain a fluorinated polyvalent carbonyl compound.
Abstract:
The racemate of 3-fluoro-alanine, and salts thereof, are prepared by reductive amination of 3-fluoro-pyruvic acid, its hydrate, or salts thereof, via the intermediate 2-imino-3-fluoro propionic acid salt, using alkali metal borohydrides as reducing agents. The racemates thus obtained are valuable in the production of 3-fluoro-D-alanine and its pharmacologically acceptable salts, and derivatives thereof, which are potent antibacterial agents.
Abstract:
This invention relates to 11,12-secoprostaglandins and processes for their manufacture. These compounds have prostaglandin-like biological activity and are particularly useful as renal vasodilators, for the treatment of hypertension, and for the prevention of thrombus formation.
Abstract:
AT LEAST ONE OF THE LATTER TWO TERMINAL GROUPS BEING PRESENT WHEN-C6F6O- REPEATING UNITS ARE PRESENT, WITH THE FURTHER PROVISO THAT WHEN SAID -CF2CO-CF3 TERMINAL GROUP IS PRESENT, ONE SAID OTHER TWO TERMINAL GROUPS IS ALSO PRESENT, AND THE CORRESPONDING ACYL HALIDES, LOWER ALKYL ESTERS AND METAL SATLS.
-CF2-COOH, -C(-CF3)-COOH, -CF2-CO-CF3
TERMINAL GROUP BONDED TO SAID CHAIN THROUGH AN ETHER OXYGEN, SAID POLYETHER HAVING TERMINAL GROUPS BONDED TO SAID CHAIN THROUGH AN ETHER OXYGEN, SAID TERMINAL GROUPS BEING SELECTED FROM THE GROUP CONSISTING OF
-CF2-CO-CF3
1. BIFUNCTIONAL PERFLUORINATED POLYETHERS AND MIXTURES THEREOF, HAVING CHEMICALLY REACTIVE TERMINAL GROUPS AT BOTH ENDS OF THE CHAIN, SAID POLYETHER HAVING 1 FROM 1 TO 100 REPEAING UNITS SELECTED FROM THE GROUP CONSISTING OF -C3F6O-, -C2F4O-, AND -CF2O-, WHREIN C2F6 AND C2F4 ARE PERFLUOROALKYLENE UNITS DERIVED FROM THE OPENING OF THE DOUBLE BOND OF A HEXAFLUOROPROPYLENE AND OF A TETRAFLUOROETHYLENE MOLECULE, RESPECTIVELY, THE DIFFERENT OXYPERFLUOROALKYLENE UNITS HAVING A RANDOM DISTRIBUTION ALONG THE CHAIN, THERE BEING NO MORE THAN 50 OFF ANY ONE OF SAID SPECIES OF REPATING UNITS, SAID -CF2OREPEATING UNITS BEING PRESENT ONLY WHEN EITHER OR BOTH OF SAID -C2FF4O- AND C3F6O- REPEATING UNITS ARE PRESENT, SAID -C2F4O -UNITS BEING PRESENT ONLY WHEN SAID -CF2O- UNITS ARE ALSO PRESENT, SAID C3F6O- UNITS BEING PRESENT ONLY WHEN EITHER SAID -CF2O- UNITS ARE ALSO PRESENT OR WHEN SAID POLYETHER CONTAINS A
Abstract:
IT IS DISCLOSED THAT CRITIC ACID AND ITS SALTS ARE PRODUCED BY REACTING A 1-HALO-2-OXO-PROPANE-3-CARBOXYLIC ACID OR A SALT OR ESTER THEREOF WITH CYANIDE TO PRODUCE A 1-HALO-2CYANO-2-HYDROXY-PROPANE-3-CARBOXYLIC ACID OR A SALT OR ESTER THEREOF, THEN CONVERTING THE 1-HALO-2-CYANO-2-HYDROXY-PROPANE-3-CARBOXYLIC ACID, ITS ESTER OR SALT TO A 1HALO-2-HYDROXY-PROPANE-2,3-DICARBOXYLIC ACID OR ITS ESTER OR SALT, THEN CONVERTING THE 1-HALO-2-HYDROXY-PROPANE-2,3DICARBOXYLIC ACID OR ITS ESTER OR SALT TO A PROPANE-2,3EPOXIDE-2,3-DICARBOXYLIC ACID OR ITS ESTER OR SALT, THEN CONVERTING THE PROPANE-1,2-EPOXIDE-2,3-DICARBOXYLIC ACID OR ITS ESTER OR SALT TO A 1-CYANO-2-HYDROXY-PROPANE-2,3DICARBOXYLIC ACID OR ITS ESTER OR SALT, THEN CONVERTING THE 1-CYANO-2-HYDROXY-PROPANE-2,3-DICARBOXYLIC ACID, ESTER OR SALT TO CITRIC ACID OR A SALT OR ESTER THEREOF. OVERALL YIELDS OF CIRTATE FROM DIKETENE ARE 60 PERCENT OR HIGHER.
Abstract:
Esters of gamma -chloroacetoacetic acid may be prepared by reacting diketene and chlorine in the presence of a low boiling organic solvent at temperatures of -10* to - 30* C. and esterifying the reaction product while maintaining the aforementioned temperatures. This process produces yields up to 87 percent of theoretical with product purity of 97 to 98 percent.
Abstract:
The invention relates to process for the continuous production of 4-chloroacetoacetyl chloride, comprising the steps of (a) feeding diketene and chlorine into a thin film reactor and (b) reacting the diketene and chlorine to obtain 4-chloroacetoacetyl chloride. The invention also relates to a process for the production of 4-chloroacetoaceticacid ester, 4-chloroacetoaceticacid amide or 4-chloroacetoaceticacid imide from 4-chloroacetoacetyl chloride obtained according to the inventive process.
Abstract:
Provided are novel symmetrical and asymmetrical bifunctional photodecomposable bases (PDBs) with dicarboxylate anion groups that show increased imaging performance. Also provided are photoresist compositions prepared with the bifunctional dicarboxylated PDBs and lithography methods that use the photoresist compositions of the present invention.